Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay
Alessandra Aiello, Andrea Coppola, Valentina Vanini, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 841-849
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic
Linda Petrone, Alessandro Sette, Rory D. de Vries, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 862-862
Open Access | Times Cited: 25
Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study
Chiara Farroni, Alessandra Aiello, Andrea Picchianti Diamanti, et al.
International Journal of Infectious Diseases (2022) Vol. 125, pp. 195-208
Open Access | Times Cited: 32
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies
Alessandra Aiello, Andrea Coppola, Serena Ruggieri, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 94, Iss. 4, pp. 290-299
Open Access | Times Cited: 22
Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination
Síle A. Johnson, Eloise Phillips, Sandra Adele, et al.
Clinical & Experimental Immunology (2023) Vol. 212, Iss. 3, pp. 249-261
Open Access | Times Cited: 13
A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies
Pascual Torres, A. Sancho-Saldaña, Anna Gil-Sánchez, et al.
Journal of Neurology (2023) Vol. 270, Iss. 5, pp. 2380-2391
Open Access | Times Cited: 11
Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose
Serena Ruggieri, Alessandra Aiello, Carla Tortorella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8525-8525
Open Access | Times Cited: 10
Kinetics of cellular and humoral immunogenicity and effectiveness of SARS‐CoV‐2 booster vaccination in hematologic neoplasms
Moraima Jiménez, Candela Fernández‐Naval, Vı́ctor Navarro, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 8, pp. 1204-1213
Closed Access | Times Cited: 6
BNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients
Evelina La Civita, Carla Zannella, Stefano Brusa, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1659-1659
Open Access | Times Cited: 6
SARS-CoV-2 specific T-cell humoral response assessment after COVID-19 vaccination using a rapid direct real-time PCR amplification
Chiara Cosma, Luisa Galla, Andrea Padoan, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 9, pp. 1652-1660
Open Access | Times Cited: 5
Improved Performance of the QuantiFERON-SARS-CoV-2 Assay with the Extended Set
Lydia Lamara Mahammed, Kahina Bensaid, Sarah Ait-Seddik, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1179-1179
Open Access | Times Cited: 5
Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy
Saeid Najafi Fard, Elisa Petruccioli, Chiara Farroni, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
SARS-CoV-2-specific T cell responses: a comparative analysis between QuantiFERON SARS-CoV-2, T-SPOT.COVID, and an in-house Omicron ELISpot
Willem A. Mak, Wendy Visser, Johannes G.M. Koeleman, et al.
Journal of Virological Methods (2024) Vol. 327, pp. 114949-114949
Open Access | Times Cited: 1
Comparative analysis between STANDARD‐E Covi‐FERON ELISA with pre‐existing IFN‐γ release assays and determination of the optimum cutoff value for assessment of T‐Cell response to SARS‐CoV‐2
Jieun Jang, Kristin Widyasari, Sun‐Joo Kim
Journal of Clinical Laboratory Analysis (2023) Vol. 37, Iss. 6
Open Access | Times Cited: 4
Pre-existing humoral immunity and CD4+ T cell response correlate with cross-reactivity against SARS-CoV-2 Omicron subvariants after heterologous prime-boost vaccination
Ching‐Fen Shen, Yi-Chen Fu, Tzong‐Shiann Ho, et al.
Clinical Immunology (2023) Vol. 251, pp. 109342-109342
Open Access | Times Cited: 4
Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis
Gianfranco Alicandro, B.S. Orena, Chiara Rosazza, et al.
Vaccine (2023) Vol. 41, Iss. 28, pp. 4114-4120
Open Access | Times Cited: 4
Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status
Arianna Gatti, Gaetano Zizzo, Massimo De Paschale, et al.
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0285728-e0285728
Open Access | Times Cited: 4
Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent Plasma
Léa Da Silva, Timothée Klopfenstein, Vincent Gendrin, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2220-2220
Open Access | Times Cited: 3
Integration of Cellular and Humoral Immune Responses as an Immunomonitoring Tool for SARS-CoV-2 Vaccination in Healthy and Fragile Subjects
Giulia Brisotto, Marcella Montico, Matteo Turetta, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1276-1276
Open Access | Times Cited: 2
Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study
Michaela Koehm, Maximilian Klippstein, Stephanie Dauth, et al.
RMD Open (2023) Vol. 9, Iss. 3, pp. e003094-e003094
Open Access | Times Cited: 2
Activating the leukocytes by short synthetic peptides in vitro as a stage in the creation of treatment-prophylactic vaccines against COVID-19
A. M. Tsygankov, О. V. Gribovskaya, В. П. Мартинович, et al.
Proceedings of the National Academy of Sciences of Belarus Medical series (2024) Vol. 21, Iss. 1, pp. 53-61
Open Access
Synthesis of SARS-CoV-2 Spike Glycoprotein Peptide Fragments and Study of Their Binding to Human Blood Cells
О. V. Gribovskaya, V. V. Yanchenko, A. M. Tsygankov, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 5, pp. 1904-1916
Closed Access
Laboratory tests for diagnostics of cell immunity against SARS-CoV-2 (review of literature)
Patrīcija Ivanova, A. V. Lobov, E. A. Pogodina, et al.
Laboratory Service (2024) Vol. 13, Iss. 3, pp. 31-31
Closed Access
Synthesis of peptide fragments spike glycoprotein SARS-CoV-2 and studying their binding with human blood cells
О. V. Gribovskaya, V. V. Yanchenko, A. M. Tsygankov, et al.
Биоорганическая химия (2024) Vol. 50, Iss. 5, pp. 636-648
Closed Access
Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody Deficiencies
Zane Lucāne, Baiba Šlisere, Gita Gersone, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1146-1146
Open Access | Times Cited: 1
A two-arm analysis of the immune response to heterologous boosting of inactivated SARS-CoV-2 vaccines
Arnone Nithichanon, Ludthawun Kamuthachad, Kanin Salao, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top